Journal article
cIAPs control RIPK1 kinase activity-dependent and -independent cell death and tissue inflammation
F Schorn, JP Werthenbach, M Hoffmann, M Daoud, J Stachelscheid, LM Schiffmann, X Hildebrandt, SI Lyu, N Peltzer, A Quaas, D Vucic, J Silke, M Pasparakis, H Kashkar
EMBO Journal | SPRINGERNATURE | Published : 2023
Abstract
Cellular inhibitor of apoptosis proteins (cIAPs) are RING-containing E3 ubiquitin ligases that ubiquitylate receptor-interacting protein kinase 1 (RIPK1) to regulate TNF signalling. Here, we established mice simultaneously expressing enzymatically inactive cIAP1/2 variants, bearing mutations in the RING domains of cIAP1/2 (cIAP1/2 mutant RING, cIAP1/2MutR). cIap1/2MutR/MutR mice died during embryonic development due to RIPK1-mediated apoptosis. While expression of kinase-inactive RIPK1D138N rescued embryonic development, Ripk1D138N/D138N/cIap1/2MutR/MutR mice developed systemic inflammation and died postweaning. Cells expressing cIAP1/2MutR and RIPK1D138N were still susceptible to TNF-induce..
View full abstractGrants
Awarded by Deutsche Krebshilfe
Funding Acknowledgements
We thank M. Menning, A. Manav and T. Roth for their technical assistance. This work was supported by the German Cancer Aid (70114685 and 70114225), SFB1403 (project number 414786233), SFB1530 (project number 455784452) and SFB1218 (project number 269925409). We thank the CECAD animal facility (University of Cologne, Germany) for support with the animal work included in this study. Open Access funding enabled and organized by Projekt DEAL.